Literature DB >> 6038609

Lipolytic effects of cyclic adenosine-3',5'-monophosphate and its butyryl derivatives in vitro, and their inhibition by alpha- and beta-adrenolytics.

A Aulich, K Stock, E Westermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6038609     DOI： 10.1016/0024-3205(67)90079-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Adenyl cyclase system and cerebral energy state.

Authors:  G Benzi; R F Villa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

2.  Effects of antilipolytic drugs on cyclic 3',5'-AMP dependent protein kinase.

Authors:  V Dinnendahl; H D Peters; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  The second messenger concept and lipid metabolism.

Authors:  R W Butcher
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Studies on the site of action of tolbutamide in the lipolytic system.

Authors:  C Rosak; K M Bartelt; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1972-07       Impact factor: 10.122

Review 5.  Hormonal control of carbohydrate and lipid metabolism and drug induced alterations.

Authors:  G Senft
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

6.  Effects of hydration and dehydration on cyclic adenosine 3',5'-monophosphate concentration in the rat kidney.

Authors:  G Senft; M Hoffmann; K Munske; G Schultz
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1968

7.  The role of cyclic adenosine-3',5'-monophosphate (AMP) in gastrointestinal secretion.

Authors:  T Scratcherd; R M Case
Journal:  Gut       Date:  1969-11       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.